KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $35.67 $42.36 Friday, 26th Apr 2024 CLDX stock ended at $36.30. This is 0.110% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.00% from a day low at $35.67 to a day high of $36.74.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jul 17, 2020 $11.01 $12.14 $11.01 $12.01 766 300
Jul 16, 2020 $10.58 $11.26 $10.45 $11.13 534 500
Jul 15, 2020 $10.58 $10.95 $10.10 $10.73 1 139 800
Jul 14, 2020 $10.80 $11.30 $10.04 $10.36 1 930 600
Jul 13, 2020 $11.53 $12.22 $11.09 $11.15 827 900
Jul 10, 2020 $12.34 $12.38 $11.28 $11.55 686 000
Jul 09, 2020 $12.09 $12.72 $11.90 $12.41 556 300
Jul 08, 2020 $12.60 $12.74 $11.75 $12.15 618 800
Jul 07, 2020 $12.47 $12.90 $12.42 $12.57 466 800
Jul 06, 2020 $12.50 $12.94 $12.42 $12.61 699 700
Jul 02, 2020 $13.64 $13.78 $12.27 $12.43 733 540
Jul 01, 2020 $13.41 $13.50 $12.50 $13.38 942 728
Jun 30, 2020 $12.46 $13.85 $12.24 $13.00 1 343 455
Jun 29, 2020 $12.40 $12.64 $11.94 $12.48 724 455
Jun 26, 2020 $12.89 $12.95 $11.40 $12.55 1 367 602
Jun 25, 2020 $12.26 $13.10 $12.05 $12.89 877 079
Jun 24, 2020 $11.98 $13.05 $11.90 $12.24 1 144 366
Jun 23, 2020 $12.79 $12.90 $11.71 $12.20 842 942
Jun 22, 2020 $13.02 $13.31 $11.21 $12.77 2 694 380
Jun 19, 2020 $10.40 $13.91 $10.40 $13.41 7 625 143
Jun 18, 2020 $10.62 $10.75 $9.96 $10.38 1 653 318
Jun 17, 2020 $10.27 $11.23 $10.18 $10.80 3 463 398
Jun 16, 2020 $11.25 $11.87 $9.77 $10.25 10 801 817
Jun 15, 2020 $7.37 $11.11 $7.35 $10.71 7 364 895
Jun 12, 2020 $9.05 $9.88 $7.12 $7.80 22 001 444
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT